BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 10695558)

  • 21. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J; Farkkilä M; Sipponen P
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eradication of Helicobacter pylori in follicular and nonfollicular gastritis.
    Mehmet S; Ozdal E; Kamil O; Beşir K; Huseyin D; Nihat A; Cigdem EY; Nusret E
    Hepatogastroenterology; 2009; 56(91-92):930-4. PubMed ID: 19621732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
    Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
    Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
    Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of eradication of Cag A Helicobacter pylori in non ulcer dyspepsia.
    Babu V; Kate V; Ananthakrishnan N
    Trop Gastroenterol; 2005; 26(4):211-4. PubMed ID: 16737055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
    Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
    Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of the efficacy of omeprazole/bismuth subcitrate or triple therapy in Helicobacter pylori gastritis. A prospective controlled study].
    Bertschinger P; Brunner J; Flury R; Lammer F; Jost R; Häcki WH
    Schweiz Med Wochenschr; 1992 Sep; 122(39):1446-51. PubMed ID: 1411403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban east Asian population.
    Khor CJ; Fock KM; Ng TM; Teo EK; Sim CS; Tan AL; Ng A
    Singapore Med J; 2000 Aug; 41(8):382-6. PubMed ID: 11256345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
    J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
    Joh T; Sasaki M; Kataoka H; Tanida S; Itoh K; Kondo Y; Ogasawara N; Oshima T; Okada N; Ohara H; Sano H; Nakao H; Sobue S; Itoh M
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1344-51. PubMed ID: 16105119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophic gastritis.
    Konturek PC; Konturek SJ; Bobrzyński A; Kwiecień N; Obtułowicz W; Stachura J; Hahn EG; Rembiarz K
    J Physiol Pharmacol; 1997 Sep; 48(3):365-73. PubMed ID: 9376619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
    Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
    Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer.
    Konturek PC; Hartwich A; Zuchowicz M; Labza H; Pierzchalski P; Karczewska E; Bielanski W; Hahn EG; Konturek SJ
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):737-49. PubMed ID: 11192946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Age and eradication treatment of duodenal ulcer].
    Minushkin ON; Volodin DV; Zverkov IV; Ivanova OI; Shuleshova AG; Burdina EG
    Ter Arkh; 2007; 79(2):22-6. PubMed ID: 17460963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.